» Articles » PMID: 12540542

Availability of Complement Bound to Staphylococcus Aureus to Interact with Membrane Complement Receptors Influences Efficiency of Phagocytosis

Overview
Journal Infect Immun
Date 2003 Jan 24
PMID 12540542
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Complement-mediated opsonization of encapsulated Staphylococcus aureus (CP+) of the predominant capsule types, 5 and 8, remains poorly understood. Our previous work showed that complement is important for mouse survival of CP+ type 5 bacteremia and that the type 5 capsule inhibits the binding of opsonic C3 fragments to the organism. The importance of complement-mediated opsonization of CP+ was tested by neutrophil phagocytosis assays. Complement-mediated opsonization of CP+ increased phagocytosis by 57% compared to opsonization in complement-inhibited serum. Agar-grown CP+, enhancing capsule expression, was phagocytosed only one-tenth as well as the capsule-negative organisms (CP-), supporting the belief that staphylococcal polysaccharide capsules impair phagocytosis. Despite relatively poor phagocytosis of CP+ compared to CP-, complement activation increased the phagocytosis of CP+ by 103%. Thus, complement in normal human serum may have an important role in opsonizing CP+, even when capsule expression is strong. The ability of bound C3 fragments to interact with complement receptor 1 (CD35) on the membrane of human erythrocytes was tested in an immune adherence assay. S. aureus capsule was able to mask C3 fragments on the organism from binding to complement receptor 1. The inhibition of C3 binding to CP+ and the masking of deposited C3 fragments caused by the presence of capsule was associated with markedly decreased phagocytosis. The addition of anti-capsule antibodies to normal human serum was found to markedly improve the recognition of deposited C3 fragments by complement receptor 1 even when the absolute number of C3 molecules bound to S. aureus was not increased.

Citing Articles

Platelet factor 4 improves survival in a murine model of antibiotic-susceptible and methicillin-resistant peritonitis.

Podolnikova N, Lishko V, Roberson R, Koh Z, Derkach D, Richardson D Front Cell Infect Microbiol. 2023; 13:1217103.

PMID: 37868353 PMC: 10585365. DOI: 10.3389/fcimb.2023.1217103.


Transcriptome and Proteome of Methicillin-Resistant Staphylococcus aureus Small-Colony Variants Reveal Changed Metabolism and Increased Immune Evasion.

Liu S, Chen H, Chen J, Wang T, Tu S, Zhang X Microbiol Spectr. 2023; :e0189822.

PMID: 36786564 PMC: 10101100. DOI: 10.1128/spectrum.01898-22.


A temperate bacteriophage isolate from Siberian tiger enhances the virulence of methicillin-resistant through distinct mechanisms.

Yang D, Wang S, Sun E, Chen Y, Hua L, Wang X Virulence. 2022; 13(1):137-148.

PMID: 34986751 PMC: 8741283. DOI: 10.1080/21505594.2021.2022276.


Complement Receptor 3 Contributes to the Sexual Dimorphism in Neutrophil Killing of .

Pokhrel S, Triplett K, Daly S, Joyner J, Sharma G, Hathaway H J Immunol. 2020; 205(6):1593-1600.

PMID: 32769122 PMC: 7484027. DOI: 10.4049/jimmunol.2000545.


In vitro evaluation of complement deposition and opsonophagocytic killing of Rhodococcus equi mediated by poly-N-acetyl glucosamine hyperimmune plasma compared to commercial plasma products.

Folmar C, Cywes-Bentley C, Bordin A, Rocha J, Bray J, Kahn S J Vet Intern Med. 2019; 33(3):1493-1499.

PMID: 31034109 PMC: 6524092. DOI: 10.1111/jvim.15511.


References
1.
RUBIN R, Harrington C, Poon A, Dietrich K, Greene J, Moiduddin A . The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis. 1999; 5(1):9-17. PMC: 2627695. DOI: 10.3201/eid0501.990102. View

2.
Smith T, Pearson M, WILCOX K, Cruz C, Lancaster M, Robinson-Dunn B . Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med. 1999; 340(7):493-501. DOI: 10.1056/NEJM199902183400701. View

3.
Portoles M, Kiser K, Bhasin N, Chan K, Lee J . Staphylococcus aureus Cap5O has UDP-ManNAc dehydrogenase activity and is essential for capsule expression. Infect Immun. 2001; 69(2):917-23. PMC: 97970. DOI: 10.1128/IAI.69.2.917-923.2001. View

4.
Cunnion K, Lee J, Frank M . Capsule production and growth phase influence binding of complement to Staphylococcus aureus. Infect Immun. 2001; 69(11):6796-803. PMC: 100057. DOI: 10.1128/IAI.69.11.6796-6803.2001. View

5.
Shinefield H, Black S, Fattom A, Horwith G, Rasgon S, Ordonez J . Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med. 2002; 346(7):491-6. DOI: 10.1056/NEJMoa011297. View